Regulation of autoantibody production by regulatory T cells expressing anergy-associated genes
Project/Area Number |
25461493
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Collagenous pathology/Allergology
|
Research Institution | The University of Tokyo |
Principal Investigator |
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2013: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Keywords | 制御性T細胞 / 自己抗体 / 全身性エリテマトーデス / LAG3 / Egr2 / TGF-β / TGF-β3 |
Outline of Final Research Achievements |
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by autoantibody production and associated with a wide range of clinical manifestations. Early growth response gene-2 (EGR2), a zinc-finger transcription factor, is known to affect susceptibility to SLE in human. We previously reported CD4+CD25-Foxp3-LAG3+ regulatory T cells (LAG3 Tregs) that characteristically express Egr2. In this study, we revealed that LAG3 Tregs, but not CD4+CD25+ Tregs, produce enormous amounts of TGF-β3 in an Egr2-dependent manner. TGF-β3 effectively suppressed autoantibody production from B cells through suppression of Syk, STAT6, and NF-κB pathways. Intriguingly, Egr3 was able to compensate the function of Egr2. These findings elucidated the mechanisms of T cell anergy-associated gene Egr2-mediated regulation of humoral immunity.
|
Report
(4 results)
Research Products
(34 results)
-
-
-
-
-
[Journal Article] TGF-β3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses2015
Author(s)
Okamura T, Sumitomo S, Morita K, Iwasaki Y, Inoue M, Nakachi S, Komai T, Shoda H, Miyazaki J, Fujio K, Yamamoto K.
-
Journal Title
Nature Communications
Volume: 6
Issue: 1
Pages: 1-14
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
-
-
[Journal Article] Transcription factor early growth response 3 is associated with the TGF-β1 expression and the regulatory activity of CD4-positive T cells in vivo.2013
Author(s)
Sumitomo S, Fujio K, Okamura T, Morita K, Ishigaki K, Suzukawa K, Kanaya K, Kondo K, Yamasoba T, Furukawa A, Kitahara N, Shoda H, Shibuya M, Okamoto A, Yamamoto K.
-
Journal Title
J Immunol
Volume: 191
Issue: 5
Pages: 2351-9
DOI
Related Report
Peer Reviewed
-
-
-
-
-
[Journal Article]2012
Author(s)
Izawa S, Okamura T, Matsuzawa K, Ohkura T, Ohkura H, Ishiguro K, Noh JY, Kamijo K, Yoshida A, Shigemasa C, Kato M, Yamamoto K, Taniguchi SI
-
Journal Title
Clin Endocrinol (Oxf)
Volume: 79
Issue: 1
Pages: 35-42
DOI
Related Report
Peer Reviewed
-
[Presentation] Inhibitory Synergistic Effect of TGF-beta and IL-10 on Humoral Immunity2015
Author(s)
Tomohisa Okamura, Kaoru Morita, Mariko Inoue, Toshihiko Komai, Yukiko Iwasaki, Shuji Sumitomo, Shinichiro Nakachi, Hirofumi Shoda, Keishi Fujio, and Kazuhiko Yamamoto
Organizer
The Second Symposium on Max Planck-The University of Tokyo Center for Integrative Inflammology
Place of Presentation
東京大学 山上会館(東京都・文京区)
Year and Date
2015-10-26
Related Report
Int'l Joint Research
-
-
-
-
-
[Presentation] TGF-β3-Producing CD4+CD25-LAG3+ Regulatory T Cells Control B Cell Responses2014
Author(s)
Tomohisa Okamura, Kaoru Morita, Mariko Inoue, Toshihiko Komai, Yukiko Iwasaki, Shuji Sumitomo, Shinichiro Nakachi, Hirofumi Shoda, Keishi Fujio, and Kazuhiko Yamamoto
Organizer
The First Symposium on Max Planck-The University of Tokyo Center for Integrative Inflammology
Place of Presentation
Harnack House, Berlin(ドイツ)
Year and Date
2014-12-16 – 2014-12-18
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-